Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction - Worldwide, 2018-2022
This report describes typhoid fever surveillance, incidence estimates, and the status of typhoid conjugate vaccine introduction during 2018-2022. Because routine surveillance for typhoid fever has low sensitivity, population-based studies have guided estimates of case counts and incidence in 10 countries since 2016 (3-6). In 2019, an updated modeling study estimated that 9.2 million (95% CI = 5.9-14.1) typhoid fever cases and 110,000 (95% CI = 53,000-191,000) deaths occurred worldwide, with the highest estimated incidence in the WHO South-East Asian (306 cases per 100,000 persons), Eastern Mediterranean (187), and African (111) regions (7). Since 2018, five countries (Liberia, Nepal, Pakistan, Samoa [based on self-assessment], and Zimbabwe) with estimated high typhoid fever incidence (≥100 cases per 100,000 population per year) (8), high antimicrobial resistance prevalence, or recent outbreaks introduced typhoid conjugate vaccines into their routine immunization programs (2). To guide vaccine introduction decisions, countries should consider all available information, including surveillance of laboratory-confirmed cases, population-based and modeling studies, and outbreak reports. Establishing and strengthening typhoid fever surveillance will be important to measure vaccine impact.PMID:36795626 | DOI:10.15585/mmwr.mm7207a2
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Molly Hancuh Jenny Walldorf Anna A Minta Carol Tevi-Benissan Kira A Christian Yoann Nedelec Kristen Heitzinger Matthew Mikoleit Amanda Tiffany Adwoa D Bentsi-Enchill Lucy Breakwell Source Type: research
More News: African Health | Antimicrobial Resistance | Education | Endemics | Epidemiology | International Medicine & Public Health | Laboratory Medicine | Liberia Health | Nepal Health | Outbreaks | Pakistan Health | Salmonella | Samoa Health | Study | Typhoid | Typhoid Vaccine | Universities & Medical Training | Vaccines | WHO | Zimbabwe Health